Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis

Ludger Klimek, Petr Cap, Gabriella Galffy, Melanie Emmeluth, Arkady Koltun, Ferdinand Kopietz, Duc Tung Nguyen, Hans Christian Kuhl, Ranny Van Weissenbruch, Wolfgang Pohl, David Price, Glennis Scadding, Joaquim Mullol

Research output: Contribution to journalArticle

Abstract

Rationale
Up to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.
Original languageEnglish
Pages (from-to)AB24-AB24
Number of pages1
JournalJournal of Allergy and Clinical Immunology
Volume145
Issue number2, Supplement
Early online date24 Feb 2020
DOIs
Publication statusPublished - Feb 2020
Event2020 AAAAI Annual Meeting - Philadelphia, United States
Duration: 13 Mar 202016 Mar 2020

Fingerprint Dive into the research topics of 'Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis'. Together they form a unique fingerprint.

  • Cite this

    Klimek, L., Cap, P., Galffy, G., Emmeluth, M., Koltun, A., Kopietz, F., Nguyen, D. T., Kuhl, H. C., Van Weissenbruch, R., Pohl, W., Price, D., Scadding, G., & Mullol, J. (2020). Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis. Journal of Allergy and Clinical Immunology, 145(2, Supplement), AB24-AB24. https://doi.org/10.1016/j.jaci.2019.12.802